• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    CHARLES & COLVARD REPORTS SECOND QUARTER FISCAL YEAR 2023 FINANCIAL RESULTS

    2/2/23 4:07:00 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary
    Get the next $CTHR alert in real time by email

    Conference Call with Accompanying Slide Presentation Scheduled Today at 4:30 PM ET

    • $10.4 million in net sales for the quarter ended December 31, 2022.
    • Generated positive cash flow from operations of $600,000 during the quarter ended December 31, 2022.
    • $17.0 million total cash as of December 31, 2022.
    • Online Channels sales were 76% of revenues in the second quarter, up from 68% in the prior year's second quarter and 62% in the second quarter of fiscal year 2021.
    • Finished jewelry represented 81% of net sales, up from 77% in the prior year's second quarter.
    • 19% increase in lab grown diamond sales during Q2 of 2023 versus the comparable year ago period and up 603% YTD 2023 versus YTD 2021 levels.
    • Opened first retail Signature Showroom location in October 2022.

    RESEARCH TRIANGLE PARK, N.C., Feb. 2, 2023 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company specializing in lab created Made, Not Mined™ gemstones, reported financial results for the second quarter ended December 31, 2022 ("Second Quarter Fiscal 2023"). 

    (PRNewsfoto/Charles & Colvard, Ltd.)

    Management Commentary 

    "We believe we are executing against our strategic initiatives to build long-term value in Charles & Colvard in order to take advantage of the transformation taking place within the industry towards lab grown gemstones and responsibly made fine jewelry," said Don O'Connell, President and CEO of Charles & Colvard. "While the macroeconomic environment has proven to be challenging in the near-term, the underlying results during the second quarter highlight the progress made against our plan to elevate our direct-to-consumer presence, enhance our company-owned brands, expand our footprint in the lab grown diamond space, and more effectively manage our balance sheet. Despite the macro conditions, we recorded $10.4 million in revenue, a level that has only been reached a handful of times in the Company's 27-year history and generated positive cash flow from operations during our second quarter."

    "We believe that Charles & Colvard is well positioned to benefit from the backdrop of responsibly-sourced and direct-to-consumer jewelry purchases, and that our Made, Not Mined™ gemstones, including our Forever One™ moissanite and Caydia® lab grown diamonds, are becoming destination brands for the conscious consumer while the enhancement of our Company-owned distribution capabilities is providing these consumers with a set of purchasing channels where they can find fine jewelry that is accessible, beautiful and conscientious. This elevation of our brands and Company-owned distribution capabilities positions us to enhance the long-term value within the business and allows us to better control our own destiny. These key areas of focus outperformed the larger top line number during the quarter which was largely impacted by the decline in our Traditional segment as we focused on our direct-to-consumer efforts," O'Connell continued.

    "With a sound strategy in place designed to take advantage of the long-term underlying shift of the consumer, coupled with a strong balance sheet, we feel good about the Company's position in the industry. As the macroeconomic environment begins to improve, we believe the results of our strategy will be achieved," O'Connell concluded.

    Financial Summary for Second Quarter Fiscal 2023

    (Quarter Ended December 31, 2022 Compared to Quarter Ended December 31, 2021)

    • Net sales of $10.4 million for the quarter, a decrease of 25% from $13.8 million in the year-ago quarter.
    • In the Online Channels segment, which consists of e-commerce outlets including charlesandcolvard.com, moissaniteoutlet.com, third-party online marketplaces, drop-ship retail and other pure-play, exclusively e-commerce outlets, net sales of $7.8 million, a decrease of 16% from the year-ago quarter, representing 76% of total net sales for the quarter, compared to $9.3 million, or 68% of total net sales in the year-ago quarter.
    • In the Traditional segment, which consists of wholesale and retail customers, net sales of $2.5 million, a decrease of 43% from the year-ago quarter, representing 24% of total net sales for the quarter, compared to $4.4 million, or 32% of total net sales, in the year-ago quarter.
    • Finished jewelry net sales of $8.4 million, a decrease of 20% for the quarter, compared to $10.5 million in the year-ago quarter.
    • Loose jewel net sales decreased 40% to $1.9 million for the quarter, compared to $3.2 million in the year-ago quarter.
    • Operating expenses increased 5% to $5.5 million for the quarter, compared to $5.3 million in the year-ago quarter, primarily due to increased investment in marketing strategies for the holiday season.
    • Income tax benefit of $132,000 for the quarter, compared to an income tax expense of $283,000 in the year-ago quarter.
    • Net loss was $1.0 million, or $0.03 loss per diluted share for the quarter, compared to net income of $1.2 million, or $0.04 earnings per diluted share, in the year-ago quarter.
    • Weighted average diluted shares outstanding were 30.3 million for the quarter, compared to 31.3 million in the year-ago quarter, partially driven by the impact of the Company's share repurchase program.

    Financial Position

    Cash, cash equivalents and restricted cash totaled $17.0 million as of December 31, 2022, representing an increase of $0.4 million from $16.6 million as of September 30, 2022, and a decrease of $4.2 million from $21.2 million as of June 30, 2022. Total inventory increased to $35.0 million as of December 31, 2022, compared to $33.5 million as of June 30, 2022. The Company had no debt outstanding as of December 31, 2022.

    Investor Conference Call

    Charles & Colvard will host an investor conference call and webcast presentation to discuss its financial results for the quarter ended December 31, 2022 at 4:30 p.m. ET on Thursday, February 2, 2023. 

    Live Call-In Information: Interested parties can access the conference call by dialing (844) 875-6912 (U.S. toll-free) or (412) 317-6708 (international) and asked to be joined to the Charles & Colvard call.

    Live Webcast Information: Interested parties can access the conference call and accompanying presentation slide via a live webcast, which is available in the Investor Relations section of the Company's website at https://ir.charlesandcolvard.com/events or https://www.webcaster4.com/Webcast/Page/346/47290.  

    A replay of this conference call will be available until February 9, 2023 at (877) 344-7529 (U.S. toll-free) or (412) 317-0088 (international). The replay conference code is 4241796. A webcast replay will be available in the Investor Relations section of the Company's website at https://ir.charlesandcolvard.com/events.

    About Charles & Colvard, Ltd.

    Charles & Colvard, Ltd. (NASDAQ:CTHR) believes that fine jewelry should be as ethical as it is exquisite. Charles & Colvard is the original creator of lab grown moissanite (a rare gemstone formed from silicon carbide). The Company brings revolutionary gems and fine jewelry to market by using exclusively Made, Not Mined™ above ground gemstones and a dedication to 100% recycled precious metals. Their Forever One™ moissanite and Caydia® lab grown diamond brands are designed to provide exceptional quality, incredible value and a conscious approach to bridal, high fashion, and everyday jewelry. Charles & Colvard was founded in 1995 and is based in North Carolina's Research Triangle Park region. For more information, please visit www.charlesandcolvard.com.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements expressing expectations regarding our future and projections relating to our products, sales, revenues, and earnings are typical of such statements and are made under the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements about our plans, objectives, representations, and contentions and are not historical facts and typically are identified by use of terms such as "may," "will," "should," "could," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "continue," and similar words, although some forward-looking statements are expressed differently.

    All forward-looking statements are subject to the risks and uncertainties inherent in predicting the future. You should be aware that although the forward-looking statements included herein represent management's current judgment and expectations, our actual results may differ materially from those projected, stated, or implied in these forward-looking statements as a result of many factors including, but not limited to, (1) our business and our results of operations could be materially adversely affected as a result of general economic and market conditions; (2) our future financial performance depends upon increased consumer acceptance, growth of sales of our products, and operational execution of our strategic initiatives; (3) the effects of COVID-19 and other potential future public health crises, epidemics, pandemics or similar events on our business, operating results, and cash flows are uncertain; (4) we face intense competition in the worldwide gemstone and jewelry industry; (5) our information technology, or IT, infrastructure, and our network may be impacted by a cyber-attack or other security incident as a result of the rise of cybersecurity events; (6) constantly evolving privacy regulatory regimes are creating new legal compliance challenges; (7) we are subject to certain risks due to our international operations, distribution channels and vendors; (8) our business and our results of operations could be materially adversely affected as a result of our inability to fulfill orders on a timely basis; (9) we are currently dependent on a limited number of distributor and retail partners in our Traditional segment for the sale of our products; (10) we may experience quality control challenges from time to time that can result in lost revenue and harm to our brands and reputation; (11) seasonality of our business may adversely affect our net sales and operating income; (12) our operations could be disrupted by natural disasters; (13) sales of moissanite and lab grown diamond jewelry could be dependent upon the pricing of precious metals, which is beyond our control; (14) our current customers may potentially perceive us as a competitor in the finished jewelry business; (15) we depend on a single supplier for substantially all of our silicon carbide, or SiC, crystals, the raw materials we use to produce moissanite jewels; if our supply of high-quality SiC crystals is interrupted, our business may be materially harmed; (16) if the e-commerce opportunity changes dramatically or if e-commerce technology or providers change their models, our results of operations may be adversely affected; (17) governmental regulation and oversight might adversely impact our operations; (18) the execution of our business plans could significantly impact our liquidity; (19) the financial difficulties or insolvency of one or more of our major customers or their lack of willingness and ability to market our products could adversely affect results; (20) negative or inaccurate information on social media could adversely impact our brand and reputation; (21) we rely on assumptions, estimates, and data to calculate certain of our key metrics and real or perceived inaccuracies in such metrics may harm our reputation and negatively affect our business; (22) we may not be able to adequately protect our intellectual property, which could harm the value of our products and brands and adversely affect our business; (23) environmental, social, and governance matters may impact our business, reputation, financial condition, and results of operations; (24) if we fail to evaluate, implement, and integrate strategic acquisition or disposition opportunities successfully, our business may suffer; (25) our failure to maintain compliance with The Nasdaq Stock Market's continued listing requirements could result in the delisting of our common stock; (26) some anti-takeover provisions of our charter documents may delay or prevent a takeover of our Company; and (27) we cannot guarantee that our share repurchase program will be utilized to the full value approved, or that it will enhance long-term stockholder value and repurchases we consummate could increase the volatility of the price of our common stock and could have a negative impact on our available cash balance, in addition to the other risks and uncertainties described in more detail in our filings with the U.S. Securities and Exchange Commission (the "SEC"), including our Annual Report on Form 10-K for the fiscal year ended June 30, 2022 and subsequent reports filed with the SEC. Forward-looking statements speak only as of the date they are made. We undertake no obligation to update or revise such statements to reflect new circumstances or unanticipated events as they occur except as required by the federal securities laws, and you are urged to review and consider disclosures that we make in the reports that we file with the Securities and Exchange Commission, or SEC, that discuss other factors relevant to our business.

    - Financial Tables Follow -

     

    Appendix A



    CHARLES & COLVARD, LTD.

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (unaudited)





    Three Months Ended December 31,



    Six Months Ended December 31,





    2022



    2021



    2022





    2021



    Net sales

    $

    10,366,122



    $

    13,753,135



    $

    17,740,204



    $



    24,033,446



            Cost of goods sold



    6,071,775





    7,033,946





    10,157,785







    12,050,496



                 Gross profit



    4,294,347





    6,719,189





    7,582,419







    11,982,950



    Operating expenses:



























    Sales and marketing



    4,339,684





    4,079,035





    7,447,630







    6,809,187



    General and administrative



    1,187,955





    1,189,559





    2,601,431







    2,773,835



    Total costs and expenses



    5,527,639





    5,268,594





    10,049,061







    9,583,022



    (Loss) Income from operations



    (1,233,292)





    1,450,595





    (2,466,642)







    2,399,928



    Other income (expense):



























            Interest income



    59,574





    490





    99,776







    845



    Loss on foreign currency exchange



    -





    -





    -







    (34)



    Total other income (expense), net



    59,574





    490





    99,776







    811



    (Loss) Income before income taxes



    (1,173,718)





    1,451,085





    (2,366,866)







    2,400,739



    Income tax benefit (expense)



    131,937





    (283,473)





    434,893







    (406,102)



    Net (loss) income

    $

    (1,041,781)



    $

    1,167,612



    $

    (1,931,973)



    $



    1,994,637



























































    Net (loss) income per common share:



























    Basic

    $

    (0.03)



    $

    0.04



    $

    (0.06)



    $



    0.07



    Diluted

    $

    (0.03)



    $

    0.04



    $

    (0.06)



    $



    0.06































    Weighted average number of shares used

         in computing net (loss) income per

         common share:



























    Basic



    30,344,954





    30,287,677





    30,408,018







    30,159,543



    Diluted



    30,344,954





    31,315,488





    30,408,018







    31,237,948































     

    CHARLES & COLVARD, LTD.

    CONDENSED CONSOLIDATED BALANCE SHEETS





    December 31, 2022

    (unaudited)



     

    June 30, 2022

    ASSETS











    Current assets:











    Cash and cash equivalents

    $

    11,960,102



    $

    15,668,361

    Restricted cash



    5,065,189





    5,510,979

    Accounts receivable, net



    2,086,868





    2,220,816

    Inventory, net



    13,091,953





    11,024,276

    Note receivable



    -





    250,000

    Prepaid expenses and other assets



    1,241,712





    1,190,012

    Total current assets



    33,445,824





    35,864,444

    Long-term assets:











    Inventory, net



    21,903,094





    22,488,524

    Property and equipment, net



    2,215,274





    1,901,176

    Intangible assets, net



    290,673





    265,730

    Operating lease right-of-use assets



    2,488,052





    2,787,419

    Note receivable



    250,000





    -

    Deferred income taxes, net



    6,286,797





    5,851,904

    Other assets



    50,300





    49,658

    Total long-term assets



    33,484,190





    33,344,411

    TOTAL ASSETS

    $

    66,930,014



    $

    69,208,855













    LIABILITIES AND SHAREHOLDERS' EQUITY











    Current liabilities:











    Accounts payable

    $

    4,860,869



    $

    4,401,229

    Operating lease liabilities, current portion



    868,269





    856,571

    Accrued expenses and other liabilities



    1,398,178





    1,546,483

    Total current liabilities



    7,127,316





    6,804,283

    Long-term liabilities:











    Noncurrent operating lease liabilities



    2,453,994





    2,846,805

    Total long-term liabilities



    2,453,994





    2,846,805

    Total liabilities



    9,581,310





    9,651,088

    Commitments and contingencies











    Shareholders' equity:











    Common stock, no par value; 50,000,000 shares

         authorized; 30,912,108 shares issued and 30,523,705

         shares outstanding at December 31, 2022 and

         30,778,046 shares issued and 30,747,759 shares

         outstanding at June 30, 2022



    57,242,211





    57,242,211

    Additional paid-in capital



    26,131,216





    25,956,491

    Treasury stock, at cost, 388,403 shares and 30,287 shares











    at December 31, 2022 and June 30, 2022, respectively



    (489,979)





    (38,164)

    Accumulated deficit



    (25,534,744)





    (23,602,771)

    Total shareholders' equity



    57,348,704





    59,557,767

    TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

    $

    66,930,014



    $

    69,208,855

     

    CHARLES & COLVARD, LTD.

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (unaudited)





    Six Months Ended December 31,





    2022



    2021



    CASH FLOWS FROM OPERATING ACTIVITIES:













    Net (loss) income

    $

    (1,931,973)



    $

    1,994,637



    Adjustments to reconcile net (loss) income to net cash (used in) provided by operating

    activities:













    Depreciation and amortization



    308,900





    238,210



    Stock-based compensation



    174,725





    478,411



    Provision for uncollectible accounts



    -





    52,000



    Provision for sales returns



    422,000





    652,000



    Inventory write-downs



    119,000





    232,000



    Provision for accounts receivable discounts



    4,899





    29,250



    Deferred income taxes



    (434,893)





    405,159



    Changes in operating assets and liabilities:













    Accounts receivable



    (292,951)





    (2,718,303)



    Inventory



    (1,601,247)





    (2,899,591)



    Prepaid expenses and other assets, net



    247,025





    (483,054)



    Accounts payable



    459,640





    2,096,372



    Accrued income taxes



    -





    943



    Accrued expenses and other liabilities



    (529,418)





    43,297



           Net cash (used in) provided by operating activities



    (3,054,293)





    121,331

















    CASH FLOWS FROM INVESTING ACTIVITIES:













    Purchases of property and equipment



    (617,283)





    (775,705)



    Payments for intangible assets



    (30,658)





    (27,730)



                  Net cash used in investing activities



    (647,941)





    (803,435)

















    CASH FLOWS FROM FINANCING ACTIVITIES:













    Stock option exercises



    -





    545,918



    Repurchases of common stock



    (451,815)





    -



                  Net cash (used in) provided by financing activities



    (451,815)





    545,918

















    NET DECREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH



    (4,154,049)





    (136,186)



    CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD



    21,179,340





    21,446,951



    CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD

    $

    17,025,291



    $

    21,310,765

















    Supplemental disclosure of cash flow information:













          Cash paid during the period for taxes

    $

    5,900



    $

    -



     

    Reconciliation to Condensed Consolidated Balance Sheets:



    December 31,

    2022





    June 30,

    2022



           Cash and cash equivalents



    $

    11,960,102





    $

    15,668,361



           Restricted cash





    5,065,189







    5,510,979



                CASH, CASH EQUIVALENTS AND RESTRICTED CASH



    $

    17,025,291





    $

    21,179,340



     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/charles--colvard-reports-second-quarter-fiscal-year-2023-financial-results-301737898.html

    SOURCE Charles & Colvard, Ltd.

    Get the next $CTHR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CTHR

    DatePrice TargetRatingAnalyst
    9/3/2021$3.50 → $3.75Buy
    Roth Capital
    More analyst ratings

    $CTHR
    SEC Filings

    See more
    • SEC Form NT 10-Q filed by Charles & Colvard Ltd

      NT 10-Q - CHARLES & COLVARD LTD (0001015155) (Filer)

      5/16/25 5:06:09 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • Charles & Colvard Ltd filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - CHARLES & COLVARD LTD (0001015155) (Filer)

      4/22/25 5:02:42 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • SEC Form 10-K filed by Charles & Colvard Ltd

      10-K - CHARLES & COLVARD LTD (0001015155) (Filer)

      4/3/25 4:45:54 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary

    $CTHR
    Leadership Updates

    Live Leadership Updates

    See more
    • Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO

      ROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that its Chief Executive Officer Arjan Haverhals will retire from his role as an officer of the company on December 31, 2024. Upon his retirement, Mr. Haverhals will continue to serve as a director on the Board and will provide consulting services to ensure continuity and support through the leadership transition. Mr. Haverhals' retirement, following a distinguished career of over 30 years in the medical device and pharmaceutical industries, reflects his desire to spend more ti

      11/14/24 4:00:00 PM ET
      $CTHR
      $MLSS
      Consumer Specialties
      Consumer Discretionary
      Industrial Specialties
      Health Care
    • Charles & Colvard Joins Russell Microcap® Index

      RESEARCH TRIANGLE PARK, N.C., June 28, 2021 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company specializing in lab created moissanite and lab grown diamonds, announced today the Company's addition to the Russell Microcap® Index, effective after the US market opens on June 28, 2021, as a part of the Russell indexes annual reconstitution. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines

      6/28/21 9:16:00 AM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary

    $CTHR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Charles & Colvard Ltd (Amendment)

      SC 13D/A - CHARLES & COLVARD LTD (0001015155) (Subject)

      2/26/24 7:00:57 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Charles & Colvard Ltd (Amendment)

      SC 13G/A - CHARLES & COLVARD LTD (0001015155) (Subject)

      2/14/24 9:00:30 AM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • SEC Form SC 13D/A filed by Charles & Colvard Ltd (Amendment)

      SC 13D/A - CHARLES & COLVARD LTD (0001015155) (Subject)

      11/20/23 4:15:12 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary

    $CTHR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Charles & Colvard, Ltd. Announces Delisting from Nasdaq

      RESEARCH TRIANGLE PARK, N.C., April 22, 2025 /PRNewswire/ -- Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company"), announced that the Company received a staff determination letter from the Nasdaq Stock Market, LLC ("Nasdaq"), informing the Company that Nasdaq determined to suspend trading and delist the Company's common stock (the "Common Stock") from Nasdaq because the Company is out of compliance with Listing Rule 5250(c)(1) for failure to timely file its Forms 10-Q for the quarters ended September 30 and December 31, 2024, unless the Company appeals this determination. The Company does not intend to request a hearing to appeal this determination. This decision was based on a car

      4/22/25 4:45:00 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • Charles & Colvard, Ltd. Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q

      RESEARCH TRIANGLE PARK, N.C., March 3, 2025 /PRNewswire/ -- Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company") (NASDAQ:CTHR) today announced that on February 25, 2025, it received an expected notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") stating that the Company continues to not be in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule"), as a result of not having timely filed its Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2024. Nasdaq previously accepted the Company's plan to regain compliance with the Listing Rule and granted the Company until April 14, 2025 to file its Annual Report on For

      3/3/25 4:45:00 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • Charles & Colvard, Ltd. Receives Interim Award in Wolfspeed Arbitration

      RESEARCH TRIANGLE PARK, N.C., Dec. 11, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company") (NASDAQ:CTHR) today announced that on December 5, 2024, it received an interim award in its confidential arbitration with Wolfspeed, Inc.  Importantly, the award rejected Wolfspeed's claims to expectation damages of approximately $22.8 million, limiting the Company's damages to just $3.3 million representing approximately $1.3 million for inventory previously purchased and approximately $2.0 million of consigned inventory in the Company's possession, that will now be recorded on the Company's balance sheet as of June 30, 2024 - along with interest, arbitration and limite

      12/11/24 4:10:00 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary

    $CTHR
    Financials

    Live finance-specific insights

    See more
    • CHARLES & COLVARD REPORTS THIRD QUARTER FISCAL YEAR 2024 FINANCIAL RESULTS

      Conference Call with Accompanying Slide Presentation Scheduled Today at 4:30 PM ET RESEARCH TRIANGLE PARK, N.C., May 2, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, reported financial results for the third quarter ended March 31, 2024 ("Third Quarter Fiscal 2024").  Management Commentary  "We remain committed to growth despite a challenging third quarter. We believe our strategic initiatives, continued investments in innovative technology, and dedica

      5/2/24 4:07:00 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • CHARLES & COLVARD TO HOST THIRD QUARTER FISCAL YEAR 2024 INVESTOR CONFERENCE CALL ON MAY 2, 2024 AT 4:30 PM ET

      RESEARCH TRIANGLE PARK, N.C., April 23, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, will host an investor conference call and webcast presentation to discuss its financial results for the third quarter ended March 31, 2024 ("Third Quarter Fiscal Year 2024") at 4:30 p.m. ET on Thursday, May 2, 2024. The Company will release its financial results after market close on the same day. Third Quarter Fiscal Year 2024 Conference Call DetailsDate and Time: T

      4/23/24 4:08:00 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • CHARLES & COLVARD REPORTS SECOND QUARTER FISCAL YEAR 2024 FINANCIAL RESULTS

      Conference Call with Accompanying Slide Presentation Scheduled Today at 4:30 PM ET RESEARCH TRIANGLE PARK, N.C., Feb. 13, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, reported financial results for the second quarter ended December 31, 2023 ("Second Quarter Fiscal 2024").  Management Commentary  "We acknowledge the recent industry shift has presented us with numerous challenges and has significantly impacted our earnings. However, we do not believe t

      2/13/24 4:07:00 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary

    $CTHR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • O'Connell Don bought $5,550 worth of shares (15,000 units at $0.37) (SEC Form 4)

      4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

      3/7/24 4:15:57 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • Sykes Ollin B bought $7,028 worth of shares (19,000 units at $0.37) (SEC Form 4)

      4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

      3/5/24 6:21:11 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • O'Connell Don bought $4,806 worth of shares (13,350 units at $0.36), increasing direct ownership by 3% to 464,464 units (SEC Form 4)

      4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

      3/5/24 9:15:15 AM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary

    $CTHR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Roth Capital reiterated coverage on Charles & Colvard with a new price target

      Roth Capital reiterated coverage of Charles & Colvard with a rating of Buy and set a new price target of $3.75 from $3.50 previously

      9/3/21 8:46:46 AM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary

    $CTHR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • O'Connell Don bought $5,550 worth of shares (15,000 units at $0.37) (SEC Form 4)

      4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

      3/7/24 4:15:57 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • Sykes Ollin B bought $7,028 worth of shares (19,000 units at $0.37) (SEC Form 4)

      4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

      3/5/24 6:21:11 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • O'Connell Don bought $4,806 worth of shares (13,350 units at $0.36), increasing direct ownership by 3% to 464,464 units (SEC Form 4)

      4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

      3/5/24 9:15:15 AM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary